XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.19.1

SHARE-BASED COMPENSATION | 3 Months Ended
--- | ---
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-Based Compensation | SHARE-BASED COMPENSATION Stock Options and Restricted Stock For the thirteen week periods ended March 31, 2019 and April 1, 2018, the Company recognized $0.3 million and $0.1 million of compensation expense related to stock awards, respectively. Unamortized share-based compensation expense as of March 31, 2019 amounted to $1.7 million which is expected to be recognized over the next 3.9 years. A summary of stock option and restricted stock activity is presented as follows:
| Number of Shares |  | Weighted Average Exercise Price Per Share |  | Weighted Average Remaining Contractual Life |  | Total Intrinsic Value of Awards (in thousands)
Awards outstanding at December 30, 2018 | 526,985 |  |  | $ | 16.49 |  |  | 7.7 |  | $ | 2,932 |
Granted | 68,750 |  |  | $ | 26.44 |  |  |  |  |
Exercised | (11,840 | ) |  | $ | 13.89 |  |  |  |  |
Forfeited / Canceled | (12,950 | ) |  | $ | 12.42 |  |  |  |  |
Awards outstanding at March 31, 2019 | 570,945 |  |  | $ | 17.83 |  |  | 7.8 |  | $ | 3,282 |
Awards exercisable at December 30, 2018 | 238,085 |  |  | $ | 13.96 |  |  | 7.2 |  | $ | 1,684 |
Awards exercisable at March 31, 2019 | 239,995 |  |  | $ | 14.68 |  |  | 7.1 |  | $ | 1,916 |
|  | Number of Shares |  | Weighted Average Grant Date Fair Value
Nonvested outstanding at December 30, 2018 |  | 288,900 |  |  | $ | 8.34 |
Nonvested outstanding at March 31, 2019 |  | 330,950 |  |  | $ | 8.54 |
For the thirteen week period ended March 31, 2019, the Company issued 4,493 shares of common stock upon the cashless exercise of 11,840 stock options. Included in awards outstanding are 29,250 shares of restricted stock, at a weighted average price per share of $28.61. For the thirteen week period ended March 31, 2019, the Company recognized $0.1 million of compensation expense related to restricted stock. Warrant Activity For the thirteen week periods ended March 31, 2019 and April 1, 2018, the Company did not recognize compensation cost related to warrants. There was no unamortized stock compensation expense to be recognized as of March 31, 2019. A summary of warrant activity is presented as follows:
| Number of Shares |  | Weighted Average Exercise Price Per Share |  | Weighted Average Remaining Contractual Life |  | Total Intrinsic Value of Options (in thousands)
Warrants outstanding at December 30, 2018 | 93,216 |  |  | $ | 11.59 |  |  | 1.3 |  | $ | 805 |
Exercised | (1,020 | ) |  | $ | 14.86 |  |  |  |  |
Warrants outstanding at March 31, 2019 | 92,196 |  |  | $ | 13.84 |  |  | 1.5 |  | $ | 516 |
Warrants exercisable at December 30, 2018 | 93,216 |  |  | $ | 11.59 |  |  | 1.3 |  | $ | 805 |
Warrants exercisable at March 31, 2019 | 92,196 |  |  | $ | 13.84 |  |  | 1.5 |  | $ | 516 |
There were no nonvested warrants outstanding at March 31, 2019 and December 30, 2018. For the thirteen week period ended March 31, 2019, the Company issued 423 shares of common stock upon the cashless exercise of 1,020 warrants. The intrinsic value in the tables above is the amount by which the market value of the underlying stock exceeded the exercise price of outstanding options or warrants, before applicable income taxes and represents the amount holders would have realized if all in-the-money options or warrants had been exercised on the last business day of the period indicated.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration